CoChat

Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target

Open access
Chu, Pei-Yu, Tai, Yu-Ling, Shen, Tang-Long · 2019 · Cells

The DOI matches its Crossref record; 82 of the 86 references it cites were found in a registry or an index.

Abstract

The partner of activated epidermal growth factor receptor (EGFR), growth factor receptor bound protein-7 (Grb7), a functionally multidomain adaptor protein, has been demonstrated to be a pivotal regulator for varied physiological and pathological processes by interacting with phospho-tyrosine-related signaling molecules to affect the transmission through a number of signaling pathways. In particular, critical roles of Grb7 in erythroblastic leukemia viral oncogene homolog (ERBB) family-mediated cancer development and malignancy have been intensively evaluated. The overexpression of Grb7 or the coamplification/cooverexpression of Grb7 and members of the ERBB family play essential roles in advanced human cancers and are associated with decreased survival and recurrence of cancers, emphasizing Grb7′s value as a prognostic marker and a therapeutic target. Peptide inhibitors of Grb7 are being tested in preclinical trials for their possible therapeutic effects. Here, we review the molecular, functional, and clinical aspects of Grb7 in ERBB family-mediated cancer development and malignancy with the aim to reveal alternative and effective therapeutic strategies.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/cells8050435

Cites

82 of 82 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Schematic structure of Grb7. Grb7 contains an N-terminal proline-rich (PR) region, a GM (Grb and Mig) region, and a C-terminal SH2 domain. The N-terminal PR region contains five minimal consensus proline-rich (PxxP) motifs that are responsible for SH3-mediated protein–protein interactions. The GM region is composed of an RA (Ral GDS/AF6 or Ras-Associating) domain, a pleckstrin homology (PH) domain, a BPS (Between the PH and SH2 domains)/PIR (phosphotyrosine interacting region) that binds to Ras, FHL2, Filamin-A, phosphoinositides, calmodulin, or insulin receptors et al. In the GM region, there are two major tyrosine phosphorylation sites at Y188 and the Y338, which can be phosphorylated by focal adhesion kinase (FAK). One serine phosphorylation site at S194 is phosphorylated by c-Jun N-terminal kinase (JNK). The phosphotyrosine motif of numerous molecules, such as the epidermal growth factor receptor (EGFR) family or FAK, has been indicated in their association with the C-terminal SH2 domain of Grb7.
Figure 1 Schematic structure of Grb7. Grb7 contains an N-terminal proline-rich (PR) region, a GM (Grb and Mig) region, and a C-terminal SH2 domain. The N-terminal PR region contains five minimal consensus proline-rich (PxxP) motifs that are responsible for SH3-mediated protein–protein interactions. The GM region is composed of an RA (Ral GDS/AF6 or Ras-Associating) domain, a pleckstrin homology (PH) domain, a BPS (Between the PH and SH2 domains)/PIR (phosphotyrosine interacting region) that binds to Ras, FHL2, Filamin-A, phosphoinositides, calmodulin, or insulin receptors et al. In the GM region, there are two major tyrosine phosphorylation sites at Y188 and the Y338, which can be phosphorylated by focal adhesion kinase (FAK). One serine phosphorylation site at S194 is phosphorylated by c-Jun N-terminal kinase (JNK). The phosphotyrosine motif of numerous molecules, such as the epidermal growth factor receptor (EGFR) family or FAK, has been indicated in their association with the C-terminal SH2 domain of Grb7.CC BY · PubMed Central
Figure 2 Signal transduction and function of Grb7 in ERBB family-mediated cancer development. ERBB family-mediated Grb7 signal transduction modulates survival, anti-apoptosis, proliferation, migration, and invasion of cancer. For instance, epidermal growth factor (EGF) stimulated-Grb7-Hax1 interactions regulate cancer apoptosis. EGF-induced Grb7 tyrosine phosphorylation activates Ras-GTPases and extracellular signal-regulated kinases 1/2 (ERK1/2) contributes to cancer proliferation. The ERBB2/Grb7-regulated Shc/Ras signal modulates cancer proliferation. The EGF signal mediates cell migration by an enhanced association and recruitment of Grb7 and Caveolin-1. Grb7 modulates cancer invasion by mediating EGF/EGFR signal-mediated ERK activation or matrix metallopeptidase 9 (MMP-9) expression. Grb7 is also involved in the integrin/FAK-, phosphoinositide-, or calmodulin-mediated cell functions. By interacting with FAK or phosphoinositides, Grb7 regulates cell migration. In addition, the interaction between Grb7 and calmodulin modulates cell angiogenic activity.
Figure 2 Signal transduction and function of Grb7 in ERBB family-mediated cancer development. ERBB family-mediated Grb7 signal transduction modulates survival, anti-apoptosis, proliferation, migration, and invasion of cancer. For instance, epidermal growth factor (EGF) stimulated-Grb7-Hax1 interactions regulate cancer apoptosis. EGF-induced Grb7 tyrosine phosphorylation activates Ras-GTPases and extracellular signal-regulated kinases 1/2 (ERK1/2) contributes to cancer proliferation. The ERBB2/Grb7-regulated Shc/Ras signal modulates cancer proliferation. The EGF signal mediates cell migration by an enhanced association and recruitment of Grb7 and Caveolin-1. Grb7 modulates cancer invasion by mediating EGF/EGFR signal-mediated ERK activation or matrix metallopeptidase 9 (MMP-9) expression. Grb7 is also involved in the integrin/FAK-, phosphoinositide-, or calmodulin-mediated cell functions. By interacting with FAK or phosphoinositides, Grb7 regulates cell migration. In addition, the interaction between Grb7 and calmodulin modulates cell angiogenic activity.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 82 references

Research works printed but not linked: 1

  1. Tanaka, 2000, Grb7 signal transduction protein mediates metastatic progression of esophageal carcinoma, J. Cell Physiol., 183, 411, 10.1002/(sici)1097-4652(200006)183:3<411::aid-jcp14>3.0.co;2-z · DOI · Paper page

Cited by

See all 94

Metadata

Authors
Chu, P.-Y., Tai, Y.-L., & Shen, T.-L.
Affiliations
National Taiwan University (TW)
Corresponding author
Shen, Tang-Long
Venue
Cells
Publisher
MDPI AG
Published
2019-05-10
Volume
8
Issue
5
Pages
435
ISSN
2073-4409 (ISSN-L)
OpenAlex
W2944451168
Cited by
84
References
86
Citations by year
2026: 5 · 2025: 10 · 2024: 13 · 2023: 9 · 2022: 34 · 2021: 9 · 2020: 3 · 2019: 1
FWCI
1.31
Type
journal article
Language
en
Open access
Locations
  • Cells (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
Ministry of Science and Technology, Taiwan (105‐2320‐B‐002‐058‐MY3, 106‐2911‐I‐002‐569)
Topics
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Mechanisms and Therapy
Keywords
Grb7, epidermal growth factor receptor, ErbB family, adaptor proteins, carcinogenesis, prognostic factors, therapeutic target, peptide inhibitors, tumor recurrence, signaling pathways
MeSH terms
Humans, Neoplasms, Biomarkers, Tumor, Signal Transduction, GRB7 Adaptor Protein, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. https://app.cochat.ai/papers/10.3390/cells8050435
The paper
Chu, P.-Y., Tai, Y.-L., & Shen, T.-L. (2019). Grb7, a Critical Mediator of EGFR/ErbB Signaling, in Cancer Development and as a Potential Therapeutic Target. Cells. https://doi.org/10.3390/cells8050435

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.